​​​​​​​​Infectious Diseases & Immunity (Jul 2022)

Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections

  • Qin Ning,
  • Tao Chen,
  • Guiqiang Wang,
  • Dong Xu,
  • Yanyan Yu,
  • Qing Mao,
  • Taisheng Li,
  • Lanjuan Li,
  • Jun Li,
  • Xiaoju Lu,
  • Jiabin Li,
  • Zhiwei Li,
  • Wenhong Zhang,
  • Yonghong Xiao,
  • Qinghua Meng,
  • Yuqiang Mi,
  • Jia Shang,
  • Yunsong Yu,
  • Yingren Zhao,
  • Caiyan Zhao,
  • Hong Zhao,
  • Jianrong Huang,
  • Jie Peng,
  • Hong Tang,
  • Xiaoping Tang,
  • Jinhua Hu,
  • Bijie Hu,
  • Wei Guo,
  • Bo Zheng,
  • Baiyi Chen,
  • Yuexin Zhang,
  • Jia Wei,
  • Jifang Sheng,
  • Zhi Chen,
  • Minggui Wang,
  • Qing Xie,
  • Yuming Wang,
  • Fu-Sheng Wang,
  • Jinlin Hou,
  • Zhongping Duan,
  • Lai Wei,
  • Jidong Jia,
  • Chinese Society of Infectious Disease of Chinese Medical Association,
  • Haijuan Wang

DOI
https://doi.org/10.1097/ID9.0000000000000055
Journal volume & issue
Vol. 2, no. 3
pp. 168 – 178

Abstract

Read online

Abstract. End-stage liver disease (ESLD) is a life-threatening clinical syndrome that markedly increases mortality in patients with infections. In patients with ESLD, infections can induce or aggravate the occurrence of liver decompensation. Consequently, infections are among the most common complications of disease progression. There is a lack of working procedure for early diagnosis and appropriate management for patients with ESLD complicated by infections as well as local and international guidelines or consensus. This consensus assembled up-to-date knowledge and experience across Chinese colleagues, providing data on principles as well as working procedures for the diagnosis and treatment of patients with ESLD complicated by infections.